Graeme Bell

Graeme Bell

No open positions remaining
59 year
Health Technology
Finance
Technology Services

Profile

Graeme Bell is the founder of Valuecycle LLC.
Mr. Bell is currently an Independent Director at Averin Capital Acquisition Corp.
since 2026, a Director at Cytoimmune Therapeutics, Inc. since 2023, a Director at Mindstate Design Labs, Inc. since 2025, and Group Chief Financial Officer at Owkin, Inc. since 2025.
Formerly, Mr. Bell was CEO, Chief Financial & People Officer at Valo Health, Inc. and Valo Health LLC from 2020 to 2024, Director-Investor Relations at Merck & Co., Inc. from 2007 to 2009, Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals LLC from 2015 to 2016, CFO, Principal Accounting Officer & Executive VP at Intellia Therapeutics, Inc. from 2016 to 2018, Chief Financial Officer at Tmunity Therapeutics, Inc. from 2018 to 2020, Director-Claims Development at Uris Group Ltd., and Head-Finance at Organon Pharma (UK) Ltd. Education includes an MBA from the University of Durham.

Graeme Bell active positions

CompaniesPositionStart
Director/Board Member 2023-02-28
Director of Finance/CFO 2025-04-30
Director/Board Member 2025-11-30

Former positions of Graeme Bell

CompaniesPositionEnd
Chief Executive Officer 2024-11-17
Chief Executive Officer 2024-11-17
Director of Finance/CFO 2020-05-31
INTELLIA THERAPEUTICS, INC. Director of Finance/CFO 2018-08-02
ANACOR PHARMACEUTICALS INC Director of Finance/CFO 2016-10-31
See the detail of Graeme Bell's experience

Training of Graeme Bell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Technology Services

Technology Services

Health Technology

Health Technology